Havana’s Center for Molecular Immunology Releases World’s First Lung Cancer ‘Vaccine’
(pictured above: Cuba’s Center for Molecular Immunology)
Looks like the United States will be forced to seriously consider whether or not we want to keep treating Cuba like a second-class country. Scientists in Havana have announced the creation, and release, of a therapeutic vaccine which reduces lung cancer from deadly disease to a chronic illness.
CimaVax-EGF isn’t a vaccine in the preventative sense—that is, it doesn’t prevent lung cancer from taking hold in new patients. It’s based on a protein related to uncontrolled cell proliferation—that is, it doesn’t prevent cancer from existing in the first place but attacks the mechanism by which it does harm.
As such it can turn aggressive later-stage lung cancer into a manageable chronic disease by creating antibodies that do battle with the proteins that cause uncontrolled cell proliferation, researchers say. Chemotherapy and radiotherapy are still recommended as a primary means of destroying cancerous tissue, but for those showing no improvement the new vaccine could be a literal lifesaver.